River Road Asset Management LLC Reduces Holdings in GE HealthCare Technologies Inc. $GEHC

River Road Asset Management LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,410,848 shares of the company’s stock after selling 544,402 shares during the quarter. GE HealthCare Technologies comprises approximately 1.3% of River Road Asset Management LLC’s investment portfolio, making the stock its 21st largest position. River Road Asset Management LLC’s holdings in GE HealthCare Technologies were worth $115,718,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in GEHC. Vanguard Group Inc. lifted its stake in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after buying an additional 267,058 shares in the last quarter. Dodge & Cox grew its stake in GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after acquiring an additional 3,693,918 shares in the last quarter. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 1.6% in the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after acquiring an additional 389,796 shares during the last quarter. State Street Corp raised its holdings in GE HealthCare Technologies by 2.0% in the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in GE HealthCare Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock worth $989,673,000 after purchasing an additional 37,159 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $61.59 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm has a market capitalization of $28.02 billion, a price-to-earnings ratio of 14.73, a PEG ratio of 1.66 and a beta of 0.74. The company’s 50-day moving average is $65.72 and its two-hundred day moving average is $74.68. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on GEHC shares. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. BTIG Research cut their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Rothschild & Co Redburn reduced their price objective on GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Mizuho lowered their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Finally, BNP Paribas Exane dropped their target price on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Nine investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $80.21.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez bought 1,750 shares of the business’s stock in a transaction on Thursday, April 30th. The stock was bought at an average price of $60.45 per share, with a total value of $105,787.50. Following the completion of the purchase, the insider directly owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Kevin Lobo bought 10,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the transaction, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired a total of 21,847 shares of company stock valued at $1,361,355 in the last ninety days. 0.36% of the stock is currently owned by corporate insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.